Neuroleptic malignant syndrome (NMS): risk factors
Evidence-based neurology checklist on neuroleptic malignant syndrome (nms): risk factors: Neuroleptic-related risk factors Previous NMS Parenteral administration Higher doses Abrupt dose reduction Depot formulation Concomitant use of Lithium and SSRIs Other risk factors Acronym
Neuroleptic-related risk factors
- Previous NMS
- Parenteral administration
- Higher doses
- Abrupt dose reduction
- Depot formulation
- Concomitant use of Lithium and SSRIs
Other risk factors
Acronym
References
- Munhoz RP, Moscovich M, Araujo PD, Tieve HAG. Movement disorders emergencies: a review. Arq Neuropsiquiatr 2012; 70:453-461.
- Strawn JR, Keck PE Jr, Caroff SN. Neuroleptic malignant syndrome. Am J Psychiatry 2007; 164:871-876.
- Nagamine T. Neuroleptic malignant syndrome associated with COVID-19 vaccination. CJEM 2022; 24:349-350.
